Trial · NCT03226067
Results by group249
Each measurement the trial posted, group by group, in the words and numbers it posted.
41 to 60 of 249
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change in Serum ALP | GKT137831 400mg Twice Daily | Percent change W12 | -14.6 | Standard Deviation 17.89 | percent change |
| Percent Change in Serum ALP | Placebo Arm | Percent change W12 | -0.6 | Standard Deviation 16.41 | percent change |
| Percent Change in Serum ALP | GKT137831 400mg Once Daily | Percent change W18 | -7.8 | Standard Deviation 21.68 | percent change |
| Percent Change in Serum ALP | GKT137831 400mg Twice Daily | Percent change W18 | -15.8 | Standard Deviation 21.42 | percent change |
| Percent Change in Serum ALP | Placebo Arm | Percent change W18 | -0.5 | Standard Deviation 15.66 | percent change |
| Percent Change in Serum ALP | GKT137831 400mg Once Daily | Percent change W24 | -9.7 | Standard Deviation 21.1 | percent change |
| Percent Change in Serum ALP | GKT137831 400mg Twice Daily | Percent change W24 | -12.9 | Standard Deviation 19.55 | percent change |
| Percent Change in Serum ALP | Placebo Arm | Percent change W24 | -3.1 | Standard Deviation 15.99 | percent change |
| Absolute Change in Serum ALP | GKT137831 400mg Once Daily | Absolute change W2 | -19.8 | Standard Deviation 35.95 | U/L |
| Absolute Change in Serum ALP | GKT137831 400mg Twice Daily | Absolute change W2 | -45.9 | Standard Deviation 75.75 | U/L |
| Absolute Change in Serum ALP | Placebo Arm | Absolute change W2 | -17 | Standard Deviation 44.4 | U/L |
| Absolute Change in Serum ALP | GKT137831 400mg Once Daily | Absolute change W6 | -27.3 | Standard Deviation 44.13 | U/L |
| Absolute Change in Serum ALP | GKT137831 400mg Twice Daily | Absolute change W6 | -58.6 | Standard Deviation 63.88 | U/L |
| Absolute Change in Serum ALP | Placebo Arm | Absolute change W6 | -14.5 | Standard Deviation 59.72 | U/L |
| Absolute Change in Serum ALP | GKT137831 400mg Once Daily | Absolute change W12 | -15.3 | Standard Deviation 67.79 | U/L |
| Absolute Change in Serum ALP | GKT137831 400mg Twice Daily | Absolute change W12 | -53 | Standard Deviation 66.51 | U/L |
| Absolute Change in Serum ALP | Placebo Arm | Absolute change W12 | -7.1 | Standard Deviation 52.75 | U/L |
| Absolute Change in Serum ALP | GKT137831 400mg Once Daily | Absolute change W18 | -27.6 | Standard Deviation 62.54 | U/L |
| Absolute Change in Serum ALP | GKT137831 400mg Twice Daily | Absolute change W18 | -53.2 | Standard Deviation 80.01 | U/L |
| Absolute Change in Serum ALP | Placebo Arm | Absolute change W18 | -6 | Standard Deviation 50.15 | U/L |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03226067/results?page=3